Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
APP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DIP2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGC57346 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC2A13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAATS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KMT2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CADPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STYXL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNIP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF103-CHMP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UTP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANGAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on